Home  - Health_Conditions - Valvular Heart Disease

Books Baby Camera Phones Computers Games DVD Electronics Kitchen Magazines Music Garden Software Tools Toys Video Apparel & Accessories Jewelry & Watches Musical Instruments Health & Personal Care Beauty Sports & Outdoors Office Products

e99.com Bookstore

Images

Newsgroups

41-60 of 107    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Valvular Heart Disease:     more books (86)

Valvular Heart Disease: Comprehensive Evaluation and Treatment (Cardiovascular Clinics) Valvular Heart Disease (Cardiology Clinics, 9:2) One in 9 seniors has valvular heart disease.(Cardiovascular Medicine): An article from: Family Practice News by Mitchel L. Zoler, 2004-12-15 Cardiology Clinics: Valvular Heart Disease by William A. (Ed) Zoghbi, 1998-01-01 Valvular Heart Disease: Comprehensive Evaluation and Management (Cardiovascular Clinics) by William S. Frankl, 1986-01 Valvular Heart Disease : First Edition by Dalen & Alpert, 1981-01-01 Netter's Cardiology Volume 3: V. Valvular Heart Disease; VI. Pericardial Diseases by Marschall Runge, 2005 Valvular Heart Disease in Clinical Practice Autopsy, in a Case of Valvular Disease of the Heart, conducted by J. by William. OSLER, 1877 The Prevention of Valvular Disease of the Heart; A Proposal to Check Rheumatic Endocarditis in Its Early Stage and Thus Prevent the Development by Richard Caton, 2009-12-17 The Prevention of Valvular Disease of the Heart. by R Caton, 1900 The Signs and Symptoms of Valvular Disease and Heart Failure (Clinical Symposia) Volume 20, Number 1 by MD Aldo Augusto Luisada, 1968 The Prevention of Valvular Disease of the Heart. a Proposal to Check Rheumatic Endocarditis in Its early Stage... by Richard Caton, 1900-01-01 The Treatment of Some of the Forms of Valvular Disease of the Heart by Arthur Ernest Sansom, 2009-12-19

lists with details

41. BHF Heart Health - Heart Conditions: Valvular Heart Disease And Pregnancy
    The British Heart Foundation (BHF) is the leading national charity fighting heart and circulatory disease the UK s biggest killer. The BHF funds research,  
    http://www.bhf.org.uk/hearthealth/index.asp?secID=1&secondlevel=77&thirdlevel=47

42. CNN - Valvular Heart Disease Associated With Fenfluramine-phentermine - June 8,
    valvular heart disease was identified in 24 women treated with We report 24 cases of unusual valvular heart disease in patients receiving treatment with  
    http://www.cnn.com/HEALTH/9707/08/fenphen.report/
    
    Extractions: Hartzell V. Schaff, M.D. From the Divisions of Cardiovascular Diseases and Internal Medicine (H.M.C., M.D.M., B.S.E.), Preventive and Occupational Medicine, Endocrinology and Internal Medicine (D.D.H.), Anatomic Pathology (W.D.E.), Thoracic and Cardiovascular Surgery (H.V.S.), Mayo Clinic and Mayo Foundation, Rochester, Minnesota, and the MeritCare Medical Center, Heart Services, Fargo, North Dakota (J.L.C.). Address reprint requests to Dr. Connolly at Mayo Clinic, 200 First Street SW, Rochester, MN 55905 NOTE: This is the manuscript of the study that has been submitted to The New England Journal of Medicine. The published version of the report may differ. ABSTRACT Background Fenfluramine and phentermine are anorectic agents individually approved by the United States Food and Drug Administration. The drugs used in combination may yield equivalent efficacy in weight reductions at lower doses of each agent and with fewer reported side effects. In 1996, the total number of prescriptions in the United States for fenfluramine and phentermine exceeded 18 million. Methods Valvular heart disease was identified in 24 women treated with fenfluramine-phentermine who had no previous history of cardiac disease. Patients presented with symptoms or a murmur. A perceived association between the clinical features and the fenfluramine-phentermine therapy evolved by communication among authors.

43. Congenital And Valvular Heart Disease And How They Effect
    Identifies risks for the diver with intracardiac defects and valvular heart problems.  
    http://www.scuba-doc.com/cngvlvhd.htm
    
    Extractions: Valvular and Congenital Heart Disease Patients that have valvular or some form of congenital heart disease have an excess strain situation that is particularly susceptible to the effects of increased exercise and blood shifting intoo the heart and lungs due to water immersion. The presence of an abnormality per se is not a contraindication to diving. In the case of intracardiac shunts due to holes in the walls, and in the presence of significant valve narrowing or widening inside the heart, diving is contraindicated. Pathophysiological Principles In considering the pathophysiology of congenital and valvular heart disease one should be aware of the effect of the lesions on the heart muscle. Overload lesions of the heart can be classed as either pressure or volume overload types. Pressure overload lesions include the enlargement of the left ventricle of the heart that results from blockage of the blood due to narrowing of the aortic valve (aortic stenosis), whereas volume overload of the left side of the heart (ventricle) can occur from leaking aortic and mitral valves (aortic or mitral regurgitation) or in the right side of the heart from a hole between the upper chambers (atria) or atrial septal defect. The response of the heart muscle to these overload states depends on whether the overload is a pressure or volume type. The myocardium appears to adapt specifically to handle the type of load imposed.

44. Antithrombotic Therapy In Valvular Heart Disease -- Native And Prosthetic: The S
    Antithrombotic therapy in valvular heart disease native and prosthetic the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  
    http://www.guideline.gov/summary/summary.aspx?view_id=1&doc_id=5895

45. Antithrombotic Therapy In Valvular Heart Disease -- Native And Prosthetic: The S
    Patients with valvular heart disease receiving oral anticoagulant (OAC) therapy Longterm Anticoagulant Therapy in a Patient with valvular heart disease  
    http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=5895&nbr=3881

46. Valvular Heart Disease - Book Information
    Drug induced valvular heart disease, 19. Prosthetic heart valves, 20. Pregnancy and valvular heart disease, 21. valvular heart disease in the elderly, 22.  
    http://www.blackwellpublishing.com/book.asp?ref=1840760583

47. Surveys Programme - Valvular Heart Disease
    In the Euro Heart Survey for valvular heart disease the following issues are addressed Current anticoagulation practice in valvular heart disease  
    http://www.escardio.org/knowledge/ehs/survey/Valvular_Heart_Disease.htm
    
    Extractions: Chairman The purpose of this survey is to collect data from a selected sample of cardiology departments throughout Europe, to evaluate the current practice in evaluation and treatment of valvular heart disease, and the accordance between existing guidelines and current practice. In the Euro Heart Survey for Valvular Heart Disease the following issues are addressed:

48. Valvular Heart Disease (WG 14) - Nucleus & Membership
    Euro Heart Survey. valvular heart disease (WG 14). Print version. Nucleus. Chairman. Prof. RJC Hall FESC, Health Policy and Practice University of East  
    http://www.escardio.org/bodies/WG/wg14/

49. Valvular Heart Disease - New Treatments, January 22, 2005
    Advances in the Evaluation and Treatment of valvular heart disease, January 22, 2005.  
    http://www.medical-library.org/journals2a/valvular_heart_disease.htm
    
    Extractions: Click here to view next page of this article Rheumatic heart disease is the leading cause of mitral stenosis in developed countries. Its incidence has declined sharply wherever standards of living have improved and where penicillin is routinely used during episodes of pharyngitis due to group A streptococcus. Occasional small epidemics still occur in the US. The major manifestations of VHD include both valvular heart disease, murmurs, aortic stenosis, mitral stenosis, mitral regurgitation, mitral prolapse, mitral valve prolapse left and right heart failure, left and right ventricular hypertrophy, atrial and ventricular arrhythmias, syncope, angina. pulmonary and systemic emboli, and endocarditis. With the exception of infectious etiologies, there are no known medical therapies that arrest the natural progression of the primary valvular stenotic or regurgitant lesions, and severe lesions ultimately require surgical therapy. Afterload reduction for chronic valvular heart disease, murmurs, aortic stenosis, mitral stenosis, mitral regurgitation, mitral prolapse, mitral valve prolapse aortic regurgitation can postpone the need for surgery, without compromising long-term outcome. Recognition of VHD Many patients with milder forms of VHD will be asymptomatic, with only a click or a murmur evident on exam. Most healthy adults do not have "benign" flow murmurs (except during pregnancy and certain systemic illnesses), and a murmur therefore usually represents some degree of valvular pathology. Correct identification of the origin of murmurs is essential, since quality of life and life span are limited in most severe forms of VHD. Murmurs due to organic VHD must be distinguished from functional murmurs caused by LV or RV dilation, hypertrophic cardiomyopathy, ischemic heart disease, or from murmurs due to intracardiac shunts and aortic coarctation. Congenital and myxomatous VHD must be identified because of the important risk of endocarditis.

50. Dx/Rx: Valvular Heart Disease
    Dx/Rx valvular heart disease Dennis A. Tighe, MD, University of Massachusetts Medical School, Theo E. Meyer, MD, University of Massachusetts Medical School  
    http://medicine.jbpub.com/catalog/0763723851/
    
    Extractions: Tightly organized into a super-condensed outline bulleted format, this handy, pocket-sized manual details precise, up-to-date information for diagnosis and treatment of Valvular Heart Disease. Throughout the book, tables and figures summarize important clinical data and current professional society recommendations, while salient references direct readers to additional information. Current, quick, and concise, for instant access on the ward or in the clinic!

51. Valvular Heart Disease
    valvular heart disease Diseases of the heart’s valves deserve much attention. valvular heart disease is treated with medicine and when necessary,  
    http://heart.uchc.edu/patientcare/services/valvular_heart.html
    
    Extractions: Diseases of the heart’s valves deserve much attention. This is particularly the case in age-related narrowing of the aortic valve. This condition is now a frequent cause of atherosclerosis in adults and the most frequent reason for aortic valve replacement in patients with aortic valve narrowing. At the UConn Health Center, cardiologists and specialists provide expert care to diagnose and treat this condition. Valvular heart disease is treated with medicine and when necessary, heart surgeons will repair or replace the narrowed or leaky valves. UConn Health Center physicians who treat patients with valvular disease include: Division of Cardiology Chair

52. Valvular Heart Diseases :: The Doctors Lounge(TM)
    valvular heart diseases Moderator Yasser Mokhtar, MD The Doctors Lounge Forum Index valvular heart diseases Mark all topics read  
    http://www.thedoctorslounge.net/cardiology/forums/viewforum.php?f=7

53. Valvular Heart Disease
    A person with valvular heart disease may have either insufficient or stenotic Symptoms for valvular heart disease can include shortness of breath and  
    http://www.health-alliance.com/learnabout/learn_valvular.htm
    
    Extractions: Normal heart valves open wide and close tight in response to changing pressure within the heart chambers. When there is valvular disease, the valves may not close tightly and blood may leak through. This is called insufficiency or regurgitation. When the valve does not open fully, it is described as stenotic. A person with valvular heart disease may have either insufficient or stenotic heart valves, or a combination of both. When heart valves do not function normally because of disease, your doctor may recommend replacement with a prosthetic (artificial) valve.

54. Phen/Fen & Valvular Heart Disease
    PHEN/FEN AND valvular heart disease July 8, 1997 QUESTIONS AND ANSWERS IS valvular heart disease RELATED TO PRIMARY PULMONARY HYPERTENSION?  
    http://www.fda.gov/cder/news/phen/phenfenqa.htm
    
    Extractions: QUESTIONS AND ANSWERS 1. WHAT IS "PHEN/FEN" ? Phentermine ("phen") and fenfluramine ("fen") are prescription medications approved by the FDA as single medicines for short-term (a few weeks) use as appetite suppressants in the management of obesity. Some physicians have prescribed them recently to be used in combination with each other and to be used for extended periods of time in weight loss programs. Such use of the products is called "off label" because there have been no studies presented to the FDA to demonstrate either the effectiveness or safety of the two drugs taken together or for longer periods of time (greater than a few weeks). "Phen" is short for phentermine , an amphetamine-like drug marketed under various trade names such as Ionamin ® and Fastin® , as well as several generic forms of phentermine. It is approved for short-term use as an appetite suppressant. "Fen" is short for

55. Valvular Heart Disease Referral Guidelines
    valvular heart disease Referral Guideline. Diagnosis/Definition. valvular heart disease can be congenital or acquired leading to valvular stenosis and/or  
    http://www.mamc.amedd.army.mil/referral/guidelines/cardio_valvular.htm
    
    Extractions: Angina Pectoris Atrial Fibrillation Congestive Heart Failure Murmurs (Adult) ... Transient Impairment of Consciousness Valvular Heart Disease Ventricular Arrhythmias MAMC Intranet or WRMC Internet Referral Guidelines Guideline Updated: 24 February 2004 Specialty: Cardiology History focused on symptoms of cardiac dysfunction (exercise tolerance, chest pain, dizziness, syncope, orthopnea), physical exam characterizing the murmur (timing, intensity, location, etc.) and looking for signs of dysfunction (rales, S3, S4, edema, jugular venous distention). PA and LAT CXR.

56. Nature Clinical Practice Cardiovascular Medicine | Is Pulmonary Vein Antrum Isol
    Patients had lone AF or one or more of valvular heart disease, Of 391 patients studied, 194 had lone AF, 102 had valvular heart disease,  
    http://www.nature.com/ncpcardio/journal/v1/n1/full/ncpcardio0019.html
    
    Extractions: @import "/common/style/layout.css";/* do not edit this stylesheet */ @import "/common/style/main.css";/* do not edit this stylesheet */ @import "/clinicalpractice/style/layout_group.css";/* do not edit this stylesheet */ @import "/clinicalpractice/style/group.css";/* do not edit this stylesheet */ @import "/ncpcardio/style/site.css";/* edit this stylesheet only */ Accessibility statement Jump to main content Jump to main navigation Jump to search ... ABOUT NPG E-MAIL: Email hcalkins@jhmi.edu This article has no abstract so we have provided the first paragraph of the full text. The approach used for catheter ablation of AF has evolved considerably since Jais et al identified the PV as an important trigger of AF. Focal ablation targeting arrhythmogenic triggers within the PVs has been replaced by more anatomically based approaches.

57. Entrez PubMed
    METHODS We identified valvular heart disease in 24 women treated with fenfluraminephentermine who had no history of cardiac disease.  
    http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9

58. Entrez PubMed
    Antithrombotic therapy in valvular heart diseasenative and prosthetic the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  
    http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1

59. BioMed Central | Full Text | Appetite Suppressants And Valvular Heart Disease &#
    Only one case of valvular heart disease was detected in 57 randomized controlled The risk of valvular heart disease is significantly increased by the  
    http://www.biomedcentral.com/1472-6904/2/6
    
    Extractions: Background Although appetite suppressants have been implicated in the development of valvular heart disease, the exact level of risk is still uncertain. Initial studies suggested that as many as 1 in 3 exposed patients were affected, but subsequent research has yielded substantially different figures. Our objective was to systematically assess the risk of valvular heart disease with appetite suppressants. Methods We accepted studies involving obese patients treated with any of the following appetite suppressants: fenfluramine, dexfenfluramine, and phentermine. Three types of studies were reviewed: controlled and uncontrolled observational studies, and randomized controlled trials. Outcomes of interest were echocardiographically detectable aortic regurgitation of mild or greater severity, or mitral regurgitation of moderate or greater severity.

60. BioMed Central | Full Text | Risk Of Valvular Heart Disease Associated With Use
    Weissman NJ Appetite suppressants and valvular heart disease. Schiller NB Fen/phen and valvular heart disease if it sounds too bad to be true,  
    http://www.biomedcentral.com/1471-2261/3/5
    
    Extractions: Background Estimates of excess risk of valvular heart disease among prior users of fenfluramine and dexfenfluramine have varied widely. Two major forms of bias appear to contribute to this variability and also result in a systematic under-estimation of risk. The first, a form of nondifferential misclassification, is the result of including background, prevalent cases among both exposed and unexposed persons in calculations of risk. The second bias results from not considering the relatively short duration of exposure to drugs. Methods We examined data from all available echocardiographic studies reporting the prevalence of aortic regurgitation (AR) and mitral regurgitation (MR) among persons exposed to fenfluramine or dexfenfluramine and a suitable control group. We also included one study in which previously existing AR or MR had been excluded. We corrected for background prevalent cases, estimated incidence rates in unexposed persons, and performed a person-years analysis of apparent incidence rates based on exposure time to provide an unbiased estimate of relative risk.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

41-60 of 107    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20